3 latest FDA approvals

Here are the three latest drugs or medical devices approved by the Food and Drug Administration this week.

1. Tremfya is a biologic drug used to treat psoriasis.

2. Endari is intended to treat serious complications associated with sickle cell disease and represents the first approved treatment for the condition in nearly two decades.

3. Blincyto is used to treat pediatric and adult patients with a specific type of acute lymphoblastic leukemia.

More articles on supply chain:

7 must-reads for supply chain leaders this week
House passes FDA user fee reauthorization bill
Are outcomes-based drug contracts effective? 5 thoughts

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars